Observer variability in a phase II trial – assessing consistency in RECIST application

Author: Skougaard Kristin   McCullagh Mark James Dusgaard   Nielsen Dorte   Hendel Helle Westergren   Jensen Benny Vittrup   Johannesen Helle Hjorth  

Publisher: Informa Healthcare

ISSN: 0284-186X

Source: Acta Oncologica, Vol.51, Iss.6, 2012-07, pp. : 774-780

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content